Nerve stimulation device for severe sleep apnea in teens with Down syndrome
Checks ongoing safety and effectiveness of Inspire therapy in young people with Down syndrome.
Key facts
- Who runs it
- Inspire Medical Systems, Inc.
- Where
- Cleveland, Houston, Orange, Phoenix, Queens, and Tampa, United StatesSee the 6 sites
- Trial code
- Registry title
- Pediatric Down Syndrome Post-Approval Study
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- Feb 2025
- Expected to end
- May 2030
- Type of study
- Interventional
- Treatments tested
- Hypoglossal Nerve Stimulation
- Record updated
- 28 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people aged 13-18 with Down syndrome and severe obstructive sleep apnea. They receive the implanted Inspire nerve stimulation device.
- Age
- 13 to 18 years
- Sex
- All sexes
- Disease stage
- Severe obstructive sleep apnea, with an AHI (breathing pauses per hour) of ≥ 10 and ≤ 50 on an in-lab sleep study done within 6 months of enrollment.
- Earlier treatment
- Positive airway pressure (such as CPAP or BiPAP) must have failed or not been tolerated. Removal of tonsils and adenoids must not be possible or must not have worked. Other treatments must have been considered.
Main reasons for not taking part
- Central plus mixed apneas over 25% of the total AHI on the recent sleep study
- Throat anatomy that would stop the device working, such as complete circular collapse of the soft palate
- A condition that harms nerve control of the upper airway
- Pregnant or planning pregnancy
- Another implanted device that may interact with the Inspire system, or need for MRI beyond the device labeling
This trial only enrols participants with Down syndrome. The registry sentence this rests on: 1. Patient has been diagnosed with Down syndrome;
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Patient has been diagnosed with Down syndrome
- Patient is 13-18 years of age
- Patient has been diagnosed with severe obstructive sleep apnea, with an AHI of ≥ 10 and ≤ 50 based on a recent (within 6 months of enrollment) qualified in-lab sleep study (PSG)
- Patient has documented failure of, or intolerance to, positive airway pressure therapies (such as CPAP or BiPAP) despite attempts to improve compliance
- Patient is contraindicated for, or not effectively treated by, adenotonsillectomy
- Treatment of patient's OSA has followed standard of care in considering all other alternative/adjunctive therapies
- Patient, and their parents/guardians, is willing to have stimulation hardware permanently implanted, and be willing to participate in follow-up visits, postoperative in-lab sleep studies (PSGs), and questionnaire completion
Who cannot take part
- Patient has any condition or procedure that has compromised neurological control of the upper airway
- Patient has a terminal illness with life expectancy of less than 12 months
- Patient's recent PSG (within 6 months of enrollment) reports central + mixed apneas > 25% of the total apnea-hypopnea index (AHI)
- Patient has any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate
- Patient, or their parent/guardian, is unable or does not have the necessary assistance to operate the patient remote
- Patient is pregnant or plans to become pregnant
- Patient has an implantable device that may be susceptible to unintended interaction with the Inspire system
- Patient will require magnetic resonance imaging (MRI) other than what is specified in the MR conditional labeling
- Any other reason the investigator deems the patient is unfit for participation in the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 13 and 18 years old?
Where in United States
- Cleveland Clinic FoundationCleveland, United StatesContact: Alex PiczerNot yet recruiting
- Baylor College of Medicine/ Texas Children's HospitalHouston, United StatesContact: Sadaf BatlaTaking people
- Children's Hospital Orange CountyOrange, United StatesContact: Eric RodriguezNot yet recruiting
- Phoenix Children s HospitalPhoenix, United StatesContact: Chase BeckermanNot yet recruiting
- Northwell Cohen Children's HospitalQueens, United StatesContact: Virginia MulloolyNot yet recruiting
- University of South Florida, Morsani College of MedicineTampa, United StatesContact: Alex CzachorNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this Post Approval research study is to assess ongoing safety and effectiveness of the Inspire therapy in adolescents and young adults (age 13-18) with Down syndrome and severe sleep apnea. The objective of the study is to provide an ongoing safety and effectiveness assessment of the Inspire UAS System in the Pediatric Down syndrome population.
The group in the trial
- Pediatric subjects with Down syndrome undergoing Inspire UAS ImplantTreatment being tested
This study is a prospective, multi-center, single-arm study of pediatric subjects (age 13-18) with Down syndrome who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) system for the treatment of severe obstructive sleep apnea (OSA).
Treatment: Hypoglossal Nerve Stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pediatric Down Syndrome Post-Approval Study
- Plain-language title
- Nerve stimulation device for severe sleep apnea in teens with Down syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06851338, who can take part
- Record updated
- 28 February 2025